Last edition
News about "Cipla biosimilars"
Cipla and Qilu Pharmaceutical Partner on Keytruda Biosimilar for US
Cipla partners with Qilu Pharmaceutical to license and supply a Keytruda (pembrolizumab) biosimilar in the US, aiming to expand access to cancer therapies.
Cipla Biosimilars | 07/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members